Historically, day treatment programs were offered to patients who were in some degree of remission from acute psychotic illness or to patients who suffered from long-term disorders (for example, personality disorders). Day treatment was viewed as superior to outpatient care because it provides more intensive treatment and rehabilitation. It experienced considerable use from the 1950s to the late 1980s. However, day treatment declined in the 1990s owing to inadequate funding arrangements and a move toward assertive community treatments.
Recently, this trend has reversed. Contributing to the renewed growth of day treatment is the recognition that, while many currently available treatments effectively reduce symptomatology, they often have minimal impact on functional impairments. This has contributed to high rates of relapse and recurrence. Multimodal treatments that focus on reducing illness and enhancing functional capacity are believed to offer an optimal intervention approach. Day treatment is seen as satisfying this need. It offers intensive and structured clinical services within a stable therapeutic milieu that typically incorporates group psychotherapy, biological psychiatry, milieu principles, and a systems orientation.
Many of the day treatment programs that have recently evolved differ from those used in the past. The newer day treatment programs are short-term (ranging from 3 to 12 weeks), whereas historically, day treatment lasted for several months. In addition, rather than being psychodynamically based, many of the new programs are guided by the principals of cognitive-behavioural therapy; nearly all new programs incorporate some insight-oriented interventions. Finally, the application of day treatment has expanded beyond the patient populations it served in the past. It is now being used for mood disorders (1), obsessivecompulsive disorder (2), postnatal depression (3), eating disorders (4), and substance abuse disorders (5) . This is not to say that the field has abandoned day treatment for patients with longer-term difficulties. Indeed, several authors have argued for longer-term day treatment for patients with personality disorders, because their response to shorter-term programs tends to be less than optimal. Considerable empirical evidence exists for the use of day treatment for personality disorders (6) .
With renewed interest comes a renewed call for more empirical research on this form of treatment. There is considerable need for studies to identify the types of disorders best suited to day treatment. Demonstration of clinical effectiveness and cost-effectiveness relative to usual outpatient care is also urgently required. Hopefully, with greater empirical support of day treatment, clinicians and administrators will further recognize its unique advantages for treating many of the debilitating and recurrent illnesses encountered in most outpatient settings.
John S Ogrodniczuk, PhD
Vancouver, British Columbia Paul I Steinberg, MD Edmonton, Alberta
Quetiapine Therapy for Corticosteroid-Induced Mania
Dear Editor: Corticosteroids are routinely used for immunosuppression in patients who have received liver transplants (1) . Mood symptoms and psychosis have long been documented as potential adverse effects of corticosteroid treatment (2) . We report a case of corticosteroid-induced mania that followed a liver transplant and that resolved with quetiapine therapy.
A white man, aged 52 years, was admitted for a liver transplant. The donor was his biological brother. Approximately 5 y ears previously, he had been diagnosed with hepatitis B and hepatitis C. He had no psychiatric history; however, his daughter had been diagnosed with bipolar disorder. After the transplant, the patient was given methylprednisolone 50 mg intravenously every 6 hours (4 doses) and then 40 mg intravenously for an additional 4 doses. Cumulatively, he received more than 250 mg of steroids before the onset of behavioural symptoms.
On postoperative day 3, psychiatry was consulted because he was talking incessantly, preoccupied with hyperreligious themes, and making hypersexual comments. He claimed that he was a prophet and that he could speak different languages; his speech contained numerous neologisms. He was grandiose and claimed to posses spiritual powers that enabled him to "sense different pleasant odours." He refused to divulge his name for "security reasons." He had not slept for the last 2 days. He was not physically aggressive or agitated. The Young Mania Rating Scale (YMRS, 3) was used to assess symptom severity; his total score was 31, indicative of mania.
On a mental status examination, he was poorly groomed and disrobed repeatedly, but he was awake, alert, cooperative, and oriented as to place, person, and time. He displayed pressure of speech and rambling speech with incoherent narration, neologisms, and loose associations. His mood was significantly elevated and euphoric. His thought content revealed grandiose delusions, ideas of reference, and hyperreligious themes. His attention, concentration, insight, and judgment were poor.
The presumptive diagnosis was steroidinduced mania. A CT scan of the head on postoperative day 3 was unremarkable. He had a benign neurological examination; there was Can J Psychiatry, Vol 50, No 1, January 2005 W 77
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